Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their positions in AstraZeneca during the third quarter of 2025, with several funds increasing holdings by over 100% according to SEC filings.
Deutsche Bank AG is a German multinational investment bank and financial services company headquartered in Frankfurt. Founded in 1870, it is dual-listed on the Frankfurt and New York stock exchanges.
Multiple institutional investors expanded their positions in AstraZeneca during the third quarter of 2025, with several funds increasing holdings by over 100% according to SEC filings.
Multiple institutional investors expanded their stakes in AstraZeneca during the third quarter of 2025, with the stock trading near its 52-week high and maintaining a "Moderate Buy" rating from analysts.
Multiple institutional investors modified their positions in AstraZeneca during the third quarter, with new stakes and adjustments reported in SEC filings. The company announced a dividend of $1.595 per share payable March 23rd.